BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang X, Fukui H, Ran Y, Xu X, Ebisutani N, Nakanishi T, Tanaka Y, Maeda A, Makizaki Y, Tomita T, Oshima T, Miwa H. Probiotic Bifidobacterium bifidum G9-1 Has a Preventive Effect on the Acceleration of Colonic Permeability and M1 Macrophage Population in Maternally Separated Rats. Biomedicines 2021;9:641. [PMID: 34204993 DOI: 10.3390/biomedicines9060641] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Hojo M, Nagahara A. Current perspectives on irritable bowel syndrome: a narrative review. J Int Med Res 2022;50:3000605221126370. [PMID: 36171718 DOI: 10.1177/03000605221126370] [Reference Citation Analysis]
2 Amedei A. Editorial of Special Issue “Pharmacomicrobiomics in Non-Communicable Disease”. Biomedicines 2022;10:1605. [DOI: 10.3390/biomedicines10071605] [Reference Citation Analysis]
3 Tang Q, Peng X, Xu B, Zhou X, Chen J, Cheng L. Current Status and Future Directions of Bacteria-Based Immunotherapy. Front Immunol 2022;13:911783. [PMID: 35757741 DOI: 10.3389/fimmu.2022.911783] [Reference Citation Analysis]
4 Dietert RR. Microbiome First Medicine in Health and Safety. Biomedicines 2021;9:1099. [PMID: 34572284 DOI: 10.3390/biomedicines9091099] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]